175 related articles for article (PubMed ID: 26297086)
1. Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign.
Simons PA; Ramaekers B; Hoebers F; Kross KW; Marneffe W; Pijls-Johannesma M; Vandijck D
Value Health; 2015 Jul; 18(5):587-96. PubMed ID: 26297086
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.
Huntington SF; Svoboda J; Doshi JA
J Clin Oncol; 2015 May; 33(13):1467-74. PubMed ID: 25823735
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.
Sher DJ; Tishler RB; Annino D; Punglia RS
Ann Oncol; 2010 May; 21(5):1072-7. PubMed ID: 19833820
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of positron emission tomography-CT in the evaluation of cancer of unknown primary of the head and neck.
Smith KA; Dort JC; Hall SF; Rudmik L
Head Neck; 2015 Dec; 37(12):1781-7. PubMed ID: 24989937
[TBL] [Abstract][Full Text] [Related]
6. Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
Jansen F; Krebber AM; Coupé VM; Cuijpers P; de Bree R; Becker-Commissaris A; Smit EF; van Straten A; Eeckhout GM; Beekman AT; Leemans CR; Verdonck-de Leeuw IM
J Clin Oncol; 2017 Jan; 35(3):314-324. PubMed ID: 27918712
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
Retèl VP; van der Molen L; Steuten LM; van den Brekel MW; Hilgers FJ
Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):709-18. PubMed ID: 25666587
[TBL] [Abstract][Full Text] [Related]
8. Investment in new technology research can save future health care dollars.
Reintgen D; Albertini J; Milliotes G; Marshburn J; Cruse CW; Rapaport D; Berman C; Glass F; Fensske N; Einstein AB; Lyman G
J Fla Med Assoc; 1997 Mar; 84(3):175-81. PubMed ID: 9143169
[TBL] [Abstract][Full Text] [Related]
9. Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature.
Wineland AM; Stack BC
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):113-6. PubMed ID: 18327029
[TBL] [Abstract][Full Text] [Related]
10. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
Oostenbrink JB; Rutten-van Mölken MP; Monz BU; FitzGerald JM
Value Health; 2005; 8(1):32-46. PubMed ID: 15841892
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
Retèl VP; van der Molen L; Hilgers FJ; Rasch CR; L'Ortye AA; Steuten LM; van Harten WH
BMC Cancer; 2011 Nov; 11():475. PubMed ID: 22051143
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of mesh prophylaxis to prevent parastomal hernia in patients undergoing permanent colostomy for rectal cancer.
Lee L; Saleem A; Landry T; Latimer E; Chaudhury P; Feldman LS
J Am Coll Surg; 2014 Jan; 218(1):82-91. PubMed ID: 24210147
[TBL] [Abstract][Full Text] [Related]
13. The Cost-Effectiveness of Cognitive-Behavioral Group Training for Patients with Unexplained Physical Symptoms.
Visser MS; Zonneveld LN; Van't Spijker A; Hunink MG; Busschbach JJ
Value Health; 2015 Jul; 18(5):570-7. PubMed ID: 26297084
[TBL] [Abstract][Full Text] [Related]
14. The economic burden of head and neck cancer: a systematic literature review.
Wissinger E; Griebsch I; Lungershausen J; Foster T; Pashos CL
Pharmacoeconomics; 2014 Sep; 32(9):865-82. PubMed ID: 24842794
[TBL] [Abstract][Full Text] [Related]
15. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of PET and PET/computed tomography: a systematic review.
Gerke O; Hermansson R; Hess S; Schifter S; Vach W; Høilund-Carlsen PF
PET Clin; 2015 Jan; 10(1):105-24. PubMed ID: 25455883
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of computed tomographic angiography before reoperative coronary artery bypass grafting: a decision-analytic model.
Gada H; Desai MY; Marwick TH
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):705-10. PubMed ID: 22933521
[TBL] [Abstract][Full Text] [Related]
18. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
19. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
